Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT03315975 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Flu Vaccine Responses in the Setting of Melanoma Treatment

StatusActive, Not Recruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 19, 2025 (before its estimated July 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary completion date: Jul 1, 2025 to Jul 1, 2026v9
  2. Primary completion date: Jul 1, 2024 to Jul 1, 2025 Completion date: Jul 1, 2024 to Jul 1, 2026v8 Show 1 more changeShow less
    • Completion date: Jul 1, 2024 to Jul 1, 2026
  3. Re-verified, no change to tracked fieldsv7
  4. Primary and study completion dates: Dec 30, 2021 to Jul 1, 2024v6
  5. Primary and study completion dates: Dec 30, 2020 to Dec 30, 2021 Trial status: Enrolling by Invitation to Active, Not Recruitingv5 Show 1 more changeShow less
    • Trial status: Enrolling by Invitation to Active, Not Recruiting
Show 3 earlier versionsHide 3 earlier versions
  1. Primary and study completion dates: Dec 30, 2019 to Dec 30, 2020v4
  2. Trial status: Recruiting to Enrolling by Invitation Site details revisedv3 Show 1 more changeShow less
    • Site details revised
  3. Trial status: Not Yet Recruiting to Recruiting Site details revisedv2 Show 1 more changeShow less
    • Site details revised
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Influenza vaccination is indicated for all adults, but the immunogenicity of vaccination has not been assessed in all situations. We are conducting a prospective unblinded study of influenza vaccine recipients.
Trial Details
NCT Number NCT03315975
Lead Sponsor University of Pennsylvania
Conditions Viral Vaccines
Enrollment 40 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov